Smithy Lecture

Surgery

The Horace G. Smithy Lectureship honors Dr. Smithy, a pioneer in the early days of cardiac surgery.  

2019 Horace G. Smithy Lecture

October 1, 2019

7 a.m. 

Bioengineering Auditorium

Dr. Krummel

 Thomas Krummel, M.D.

Emile Holman Professor, and Professor, by courtesy, of Cardiothoracic Surgery and of Bioengineering

 Co-director, Stanford Byers Center for Biodesign

Stanford University 

Recent Past Speakers (Note: 2018 lecture was cancelled due to hurricane)

2018  W. Randolph Chitwood, Jr. M.D. Innovators and Innovation in Cardiac Surgery: Past, Present, and Future
2017  David R. Jones, M.D.  Current Management of Stage III(N2) NSCLC 
2015 Vaughn A. Starnes, M.D. Opening Doors: A Surgeon’s Journey Over Thresholds
2014 Martin Elliott, M.D.  10 Commandments for Safety in the Operating Room 
2013 Shafique Keshavjee, M.D.
The Future of Transplantation: Personalized Medicine for the Organ
2012  Lawrence H. Cohn, M.D. How to be a Safe and Effective Surgeon
2011  Leonard Lee Bailey, M.D. Evolution of Infant Heart Transplantation
2010 G. Alexander Patterson, M.D. Tribal Leadership in Surgery

About

On January 30, 1948, Dr. Smithy was a young Assistant Professor of Surgery at MUSC who made medical history by successfully removing scar tissue from a heart valve of a young, incapacitated girl who had been given but a brief time to live.  

The technique employed by the 34-year old Horace G. Smithy was based upon two years of exhaustive research experimentation. Dr. Smithy’s research included the design of a new instrument, known as a valvulotome, to cut scar tissue blocking heart valves of rheumatic fever victims.  He subsequently operated upon six additional patients, four of whom survived.  

Tragically, Dr. Smithy himself had valvular heart disease as a result of rheumatic fever during childhood, and his condition began rapidly deteriorating and Dr. Smithy died on October 28, 1948. However, from his pioneering efforts, enormous progress has been made. Today, reliable prosthetic heart valves are widely available and surgery for valvular heart disease is standardized and carries a very low risk in most individuals.


 Innovators and Innovation in Cardiac Surgery: Past, Present, and Future

 Innovators and Innovation in Cardiac Surgery: Past, Present, and Future

 Innovators and Innovation in Cardiac Surgery: Past, Present, and Future

 Innovators and Innovation in Cardiac Surgery: Past, Present, and Future

 Innovators and Innovation in Cardiac Surgery: Past, Present, and Future